Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Cancers (Basel) ; 12(6)2020 Jun 10.
Artigo em Inglês | MEDLINE | ID: mdl-32532107

RESUMO

Human papillomavirus (HPV) has been implicated in the etiology of a variety of human cancers. Studies investigating the presence of high-risk (HR) HPV in breast tissue have generated considerable controversy over its role as a potential risk factor for breast cancer (BC). This is the first investigation reporting the prevalence and type distribution of high-risk HPV infection in breast tissue in the population of Qatar. A prospective comparison blind research study herein reconnoitered the presence of twelve HR-HPV types' DNA using multiplex PCR by screening a total of 150 fresh breast tissue specimens. Data obtained shows that HR-HPV types were found in 10% of subjects with breast cancer; of which the presence of HPV was confirmed in 4/33 (12.12%) of invasive carcinomas. These findings, the first reported from the population of Qatar, suggest that the selective presence of HPV in breast tissue is likely to be a related factor in the progression of certain cases of breast cancer.

2.
Sci Rep ; 7: 43591, 2017 02 27.
Artigo em Inglês | MEDLINE | ID: mdl-28240743

RESUMO

Infection by human papillomaviruses (HPVs) has been implicated in the aetiology of a variety of cancers. Studies evaluating the presence of HPVs in breast cancer (BC) have generated considerable controversy. To date, most studies have focused on the presence of viral DNA in BC; however there are important gaps in evidencing the role of HPV persistence in the invasiveness of BC. While these studies have been conducted in several countries, none, on the presence and biological activity of high risk (HR) HPV in BC has been done in the UK. Hence, we aimed to investigate these gaps by screening a total of 110 fresh breast tissue specimens from UK patients for the presence of twelve HR-HPV types DNA using PCR and Sanger sequencing. Samples positive for HPV-DNA were screened for viral oncoprotein expression using western blot and dot blot. Data obtained showed the presence of HR-HPVs in 42% of breast tissues of which the viral activity was only confirmed in a number of invasive carcinomas (5/26). This finding, the first to report in the UK, suggests that the selective expression of viral oncoprotein in invasive cases may propose a role for HR-HPVs in the development of some types of BC.


Assuntos
Neoplasias da Mama/epidemiologia , Neoplasias da Mama/etiologia , Papillomaviridae , Infecções por Papillomavirus/complicações , Adulto , Idoso , Idoso de 80 Anos ou mais , DNA Viral , Feminino , Genótipo , Humanos , Pessoa de Meia-Idade , Proteínas Oncogênicas Virais/genética , Proteínas Oncogênicas Virais/metabolismo , Papillomaviridae/classificação , Papillomaviridae/genética , Papillomaviridae/metabolismo , Infecções por Papillomavirus/virologia , Reação em Cadeia da Polimerase , Prevalência , Análise de Sequência de DNA , Reino Unido/epidemiologia
3.
J Surg Case Rep ; 2016(11)2017 Jan 09.
Artigo em Inglês | MEDLINE | ID: mdl-28069872

RESUMO

Primary ectopic breast carcinoma in male is very rare. We report a case on a 52-year-old gentleman who presented initially with bilateral lesions in his axilla and after delayed diagnosis the right lesion was confirmed as an ectopic breast carcinoma. We reviewed the literature and discussed the significance of the case.

4.
J Clin Anesth ; 34: 427-31, 2016 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27687427

RESUMO

STUDY OBJECTIVES: To determine the effectiveness of serratus plane block performed under direct vision on postoperative pain after mastectomy. DESIGN: We performed a retrospective study of elective breast surgery patients undergoing mastectomy over 6 months. We collected data on the outcomes for the pain score and use of analgesia in recovery, the use of analgesia and antiemetics overnight, and the pain score and mobilization status of the patient 1 day after the operation. SETTING: Breast cancer is the most common cancer in women, and mastectomy is commonly performed as part of the management. A mastectomy can cause significant acute pain which progresses to chronic pain in 25% to 60% of women. Recent studies have suggested that a serratus plane block is a viable alternative to regional anesthetic techniques without the side effect profile and that injection of local anesthetic into serratus anterior provided predictable and effective anesthesia to the chest wall. Serratus blocks target the thoracic nerves more selectively than pectoral blocks, and local blocks can reduce the use of opiates postoperatively thereby lessening opiate-related side effects. PATIENTS: Our sample included 16 patients who had received a serratus block and 11 patients who only had wound infiltration with levobupivacaine with adrenaline and clonidine. INTERVENTION: Serratus plane block was conducted by injecting 50% of the totally available levobupivacaine 0.375% with adrenaline and clonidine deep to serratus anterior under direct observation. MAIN RESULTS: No patients receiving a serratus block suffered severe pain in recovery or day 1 postoperatively. Patients receiving wound infiltration alone had 2 patients suffering severe pain in recovery and 3 patients suffering severe pain day 1 postoperatively. CONCLUSION: Serratus block provides effective regional anesthesia, suitable for mastectomies, and currently appears to be superior to wound infiltration alone. However, further data will need to be collected to support this finding.


Assuntos
Anestesia Local/métodos , Mastectomia/efeitos adversos , Bloqueio Nervoso/métodos , Manejo da Dor/métodos , Dor Pós-Operatória/terapia , Nervos Torácicos/efeitos dos fármacos , Analgésicos/administração & dosagem , Analgésicos/uso terapêutico , Anestesia Local/efeitos adversos , Anestésicos Locais/uso terapêutico , Neoplasias da Mama/cirurgia , Bupivacaína/administração & dosagem , Bupivacaína/análogos & derivados , Bupivacaína/uso terapêutico , Clonidina/administração & dosagem , Clonidina/uso terapêutico , Feminino , Humanos , Injeções Intramusculares , Levobupivacaína , Bloqueio Nervoso/efeitos adversos , Estudos Retrospectivos , Resultado do Tratamento
5.
Breast Cancer Res Treat ; 123(3): 829-36, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20697803

RESUMO

Cyclo-oxygenase 2 (COX-2) is implicated in the regulation of aromatase transcription in malignant breast tissue and has been considered as a potential target for tissue specific aromatase suppression. We initiated a randomised controlled pre-surgical study of celecoxib versus no treatment in women with primary breast cancer to determine the effects of COX-2 inhibition on markers of biological response. Postmenopausal women (50-80 years of age) with stage I or II, primary breast cancer, were randomised 2:1 to receive 400 mg/day celecoxib or no treatment for 14 days prior to surgery. A core biopsy was obtained pre- and post-treatment. Paired baseline and endpoint biopsies were analysed for Ki67, apoptosis, COX-2, CD31, estrogen receptor (ER) and progesterone receptor (PgR). Comparisons between the treatment groups were conducted using the Mann-Whitney test with a two-sided 5% significance. Of the 25 patients treated, 23 had evaluable data and 19 (83%) were ER positive. Overall the geometric mean change in Ki67, the primary end point, relative to baseline in the celecoxib arm was -16.6% (P = 0.056). The change in the no-treatment group was -8.1% (P = 0.24). There was no statistically significant difference in the change between the two groups. Celecoxib did not significantly affect apoptosis, COX-2, ER or PgR expression. There is only modest evidence for a biological effect of celecoxib in primary breast cancer. However, the trend towards a reduction in Ki67 in ER-positive breast cancer warrants further investigations in a larger cohort of patients.


Assuntos
Antineoplásicos/administração & dosagem , Neoplasias da Mama/tratamento farmacológico , Inibidores de Ciclo-Oxigenase 2/administração & dosagem , Ciclo-Oxigenase 2/metabolismo , Pirazóis/administração & dosagem , Sulfonamidas/administração & dosagem , Idoso , Idoso de 80 Anos ou mais , Apoptose/efeitos dos fármacos , Biópsia , Neoplasias da Mama/enzimologia , Neoplasias da Mama/patologia , Neoplasias da Mama/cirurgia , Celecoxib , Proliferação de Células/efeitos dos fármacos , Quimioterapia Adjuvante , Esquema de Medicação , Feminino , Humanos , Antígeno Ki-67/metabolismo , Londres , Pessoa de Meia-Idade , Terapia Neoadjuvante , Estadiamento de Neoplasias , Molécula-1 de Adesão Celular Endotelial a Plaquetas/metabolismo , Pós-Menopausa , Receptores de Estrogênio/metabolismo , Receptores de Progesterona/metabolismo , Fatores de Tempo , Resultado do Tratamento
6.
Opt Express ; 16(9): 5997-6007, 2008 Apr 28.
Artigo em Inglês | MEDLINE | ID: mdl-18545301

RESUMO

We report diffuse reflection imaging in air of concealed powdered samples using a terahertz quantum cascade laser. The sensitivity of the detection scheme to sub-surface absorption within samples is confirmed using fully-characterized powdered admixtures of polystyrene and polymethyl methacrylate (PMMA). Measurements of the backscattering intensity from these samples are then used in conjunction with Kubelka-Munk scattering theory, as well as several models based on the quasi-crystalline approximation, to extract the absorption coefficient of PMMA. Our research demonstrates the feasibility of high-resolution frequency-domain terahertz imaging for the detection and identification of concealed powders in a reflection geometry.


Assuntos
Imageamento Tridimensional , Lasers Semicondutores , Pós/análise , Absorção , Cristalografia , Difusão , Luz , Polietileno/química , Polimetil Metacrilato/química , Espalhamento de Radiação
7.
ANZ J Surg ; 78(4): 269-72, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18366399

RESUMO

BACKGROUND: Oncoplastic breast surgery is an integral and fundamental component of the clinical management of breast cancer. The aim of this study was to determine the proportion of oncoplastic and reconstructive breast cancer procedures undertaken within a specialist breast practice. METHODS: An audit of breast-related cancer procedures was undertaken for patients with early breast cancer between 1 January 2001 and 31 December 2005, treated at the Royal Adelaide Hospital and in private practice. The proportion of oncoplastic and breast reconstructive procedures was calculated to determine the clinical effects on a specialist breast-surgical practice. RESULTS: Breast cancer resection procedures accounted for 1514 of 2113 of operations (72%). Most of these (897 of 1514, 59.2%) were wide local excision or re-excision procedures. Total breast reconstruction operations (i.e. autogenous tissue flaps, tissue expander/implant reconstructions) accounted for 251 procedures. Of these, 67 (26.7%) were carried out at the time of simple mastectomy. Contralateral breast procedures (i.e. reduction mammaplasty, mastopexy and augmentation) accounted for 138 procedures and nipple-areola reconstruction/tattoo accounted for 153 procedures. Oncoplastic procedures, such as skin-sparing mastectomy, latissimus dorsi miniflap and therapeutic mammaplasty accounted for 57 of 599 procedures (9.5%). Breast reconstruction and oncoplastic operations accounted for 599 of 2113 procedures (28%). CONCLUSION: Specialist breast surgeons trained in breast reconstruction and oncoplastic techniques can expect a substantial proportion of their breast practice to include such operative procedures (28% in this series). Subspecialist training in breast surgery should incorporate experience in breast reconstructive and aesthetic surgery for trainees who wish to practise as specialist breast surgeons in the future.


Assuntos
Neoplasias da Mama/cirurgia , Mamoplastia/estatística & dados numéricos , Mastectomia/estatística & dados numéricos , Feminino , Humanos , Especialidades Cirúrgicas
8.
ANZ J Surg ; 77(9): 774-7, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17685957

RESUMO

BACKGROUND: Surgeon-performed ultrasound (SPU) and (99m)Tc-sestamibi (SM) scanning can be used alone or in combination in patients with primary hyperparathyroidism to select cases suitable for minimally invasive parathyroidectomy (MIP). The aim of the study was to evaluate SPU and SM and to determine the reliability they provide the surgeon in planning and carrying out MIP. METHODS: The study was a prospective analysis of 130 patients with primary hyperparathyroidism who had preoperative localization with SPU and SM at a tertiary referral centre between 2003 and 2006. All ultrasound scans were carried out by one surgeon, followed by correlative sestamibi scan and a further 'on operating table' ultrasound to reassess the lesion and mark the operative site. Selection criteria for MIP were a positive SPU and SM, although a positive SPU or SM allowed the surgeon to focus on the nominated side. SPU and SM localizations were correlated to the operative findings. RESULTS: One hundred and thirty patients underwent both SPU and SM. There were 97 women and 33 men, with a mean age of 59 years. SPU alone identified the abnormal parathyroid in 103 cases (sensitivity 82%; positive predictive value 96.3%). SM alone identified the abnormal gland in 102 cases (sensitivity 79%; positive predictive value 99%). In 88 patients, the SPU and SM were concordant, and 94% had successful MIP. SPU and SM were both negative in 13 patients, and all these patients had bilateral neck exploration. CONCLUSION: SPU in the hands of an experienced surgeon in association with sestamibi is a reliable tool for the preoperative localization of parathyroid adenomas and facilitates a minimally invasive procedure.


Assuntos
Hiperparatireoidismo Primário/diagnóstico , Hiperparatireoidismo Primário/cirurgia , Paratireoidectomia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Hiperparatireoidismo Primário/diagnóstico por imagem , Masculino , Pessoa de Meia-Idade , Cintilografia , Compostos Radiofarmacêuticos , Tecnécio Tc 99m Sestamibi , Ultrassonografia
9.
Phys Rev Lett ; 93(23): 237403, 2004 Dec 03.
Artigo em Inglês | MEDLINE | ID: mdl-15601202

RESUMO

A terahertz quantum cascade laser, operating at lambda=159 microm and exploiting the in-plane confinement arising from perpendicular magnetic field, is used to investigate the physics of electrons confined on excited subbands in the regime of a large ratio of the magnetic field confinement energy to the photon energy. As the magnetic field is increased above about 6 T, and the temperature lowered below 20 K, the devices are characterized by a very low threshold current density, with values as low as J(th)=1A/cm(2), and an increase of gain by five times the low field value. We show that, as with the quantum Hall effect, the key physical process is the localization of the carriers. Evidences for resonant electron-electron scattering processes are directly obtained from light intensity and transport measurements.

10.
Opt Lett ; 29(1): 122-4, 2004 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-14719681

RESUMO

Quantum-cascade lasers operating at 4.7, 3.5, and 2.3 THz have been used to achieve cyclotron resonance in InAs and InSb quantum wells from liquid-helium temperatures to room temperature. This represents one of the first spectroscopic applications of terahertz quantum-cascade lasers. Results show that these compact lasers are convenient and reliable sources with adequate power and stability for this type of far-infrared magneto-optical study of solids. Their compactness promises interesting future applications in solid-state spectroscopy.

11.
Clin Cancer Res ; 9(7): 2651-6, 2003 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12855643

RESUMO

PURPOSE: Cyclooxygenase (COX)-2 is overexpressed in breast cancer and may have a role in regulating tumor growth via effects on angiogenesis, cell proliferation, or apoptosis. This study aimed to derive data from human breast carcinomas to help substantiate or refute these relationships. EXPERIMENTAL DESIGN: We performed immunohistochemical analysis of a set of 86 breast tumors for COX-2, estrogen receptor (ER), progesterone receptor (PGR), HER-2, Ki67 (a marker of proliferation), and CD31 (an endothelial cell marker of angiogenesis). RESULTS: COX-2 protein expression was detected in 79% of all tumors studied, ER was detected in 79% of all tumors studied, PGR was detected in 73% of all tumors studied, and HER-2 was detected in 16% of all tumors studied. COX-2 protein expression did not significantly correlate with tumor size, grade, axillary lymph node status, or the presence of vascular invasion. A significant negative correlation (P < 0.001) was observed between ER and Ki67. COX-2 expression showed a significant linear correlation with CD31 staining (P < 0.001). No significant correlations were observed between COX-2 and ER, PGR, or HER-2. CONCLUSIONS: This study demonstrates a novel relationship between COX-2 expression and the neovasculature of human breast adenocarcinomas. If this is a functional relationship, it provides support for a potential therapeutic role of COX-2 inhibitors in human breast cancer tissue via their antiangiogenic properties.


Assuntos
Neoplasias da Mama/enzimologia , Regulação Enzimológica da Expressão Gênica , Isoenzimas/biossíntese , Neovascularização Patológica , Prostaglandina-Endoperóxido Sintases/biossíntese , Adulto , Idoso , Apoptose , Divisão Celular , Linhagem Celular Tumoral , Ciclo-Oxigenase 2 , Humanos , Imuno-Histoquímica , Hibridização in Situ Fluorescente , Antígeno Ki-67/biossíntese , Metástase Linfática , Proteínas de Membrana , Pessoa de Meia-Idade , Molécula-1 de Adesão Celular Endotelial a Plaquetas/biossíntese , Receptor ErbB-2/biossíntese , Receptores de Estrogênio/biossíntese , Receptores de Progesterona/biossíntese
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA